In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
Margaret M. Billingsley(Massachusetts Institute of Technology), Michael J. Mitchell(California Institute for Regenerative Medicine), Alvin J. Mukalel(University of Pennsylvania), Lulu Xue(University of Pennsylvania), Alex G. Hamilton(California University of Pennsylvania), Ningqiang Gong(University of Science and Technology of China), Ann E. Metzloff(University of Pennsylvania), Savan K. Patel(Broad Institute), Kelsey L. Swingle(University of Pennsylvania), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Rakan El‐Mayta(University of Pennsylvania), Hamideh Parhiz(Translational Therapeutics (United States)), Hannah C. Safford(University of Pennsylvania), Xuexiang Han(Center for Excellence in Molecular Cell Science), Ajay S. Thatte(University of Pennsylvania), Tyler E. Papp(Translational Therapeutics (United States))
Cited by 216
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment
|Nature Nanotechnology|2019|598
An ionizable lipid toolbox for RNA delivery
|Nature Communications|2021|581